register

Human Resources

Flexible work: likely or lip service beyond COVID-19 pandemic?

Health Industry Hub | June 15, 2020 |

Flexible work has always been a drawcard for employees, but while managers have typically been reluctant to embrace flexible work arrangements, University of South Australia researchers warn that the topic is likely to become front and centre as employees return to the office after months of lockdown from COVID-19.

Human resource management experts, UniSA’s Professor Carol Kulik and Dr Ruchi Sinha say organisations should be prepared to discuss alternative work arrangements.

While more than 80 per cent of Australian businesses offer scope for flexible work practice, only 17 per cent embrace flexibility, leaving much room for improvement.

“COVID-19 forced people to work from home under the worst possible conditions – it was done in a rush, it was done across the board, and in some cases, it was done without the right supports such as IT, or ergonomics,” Dr Sinha says.

Register & join 22,000+ industry professionals in reading the latest industry news & engaging content from Health Industry Hub, the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.

“Yet, even under these sub-optimal conditions, the pandemic showed that flexibility can work, with many people thriving in their safe, home-bound conditions.

“Of course, not everyone loved it, but the work did get done, and employees did show that working from home is not only possible, but also productive.

“Now, as workplaces return to some semblance of normal, people are asking – ‘what will happen to workplace flexibility?’ – and with such large-scale evidence that flexibility doesn’t diminish productivity, businesses cannot afford to turn a blind eye and just return to normal.

“Beyond COVID-19, we need a next normal that will not only embrace lessons from the lockdown, but also encourage flexible work.”

The way forward, according to Professor Carol Kulik, is by ‘job crafting’ – the notion that each job can be crafted to match the nature of the job and needs of worker.

Prof Kulik says a balance will be necessary to navigate recovery post COVID-19.

“No doubt we’re going to need give-and-take when it comes to flexible working arrangements – both for employers and employees,” Prof Kulik says.

“Managers need to recognise that they are often the biggest barriers to negotiating flexible work, simply because they aren’t well-prepared to motivate or manage staff remotely. They’re also concerned about productivity from home, so all in all, it’s easier for them to say no to flexibility, than it is to say yes.

In alignment with the Government’s mental health initiative the #SelfcareInHealthcare campaign has been launched to support Pharma, Biotech and MedTech industry professionals. The initiative is supported by Medicines Australia, AusBiotech, MTAA and ARCS Australia. Learn more.

“On the other hand, while the pandemic has afforded us the opportunity to prove we can work flexibly, employees must recognise that not all work tasks are conducive to remote execution.

“The solution, we believe, is somewhere in the middle, and through ‘job crafting,’ employees and managers can negotiate a better fit between the job role and the individual’s needs, skills and passions, with the result being both higher efficiency, engagement and loyalty.

“Organisations that proactively use this recovery time to re-evaluate their assumptions of flexible work are likely to be leaps and bounds ahead of their competitors.

“By crafting roles and performance criterion effectively, these organisations are more likely to retain their talent, attract new talent and thrive. It’s time to stop paying lip service to flexible workplace policies. It’s time to see change.”


News & Trends - MedTech & Diagnostics

APAC medtech company scores TGA approval in heart disease

APAC medtech company scores TGA approval in heart disease

Health Industry Hub | October 4, 2024 |

MedTech & Diagnostics News: An Asia Pacific medtech company has announced that its flagship drug-eluting stent (DES) has received regulatory […]

More


News & Trends - MedTech & Diagnostics

New state-based pilot to back home-grown medtech innovation

New state-based pilot to back home-grown medtech innovation

Health Industry Hub | October 4, 2024 |

MedTech & Diagnostics: In a bid to enhance opportunities for local medtech manufacturers to sell to health services, a connected […]

More


News & Trends - Pharmaceuticals

Ferring unveils first real-world evidence for faecal calprotectin approach in ulcerative colitis

Ferring unveils first real-world evidence for faecal calprotectin approach in ulcerative colitis

Health Industry Hub | October 4, 2024 |

Pharma News: Ferring Pharmaceuticals has announced results from a new study, which provides the first real-world evidence supporting the efficacy […]

More


News & Trends - Pharmaceuticals

Bayer partners with RACGP, calls for MBS reforms to boost access to long-acting contraceptives

Bayer partners with RACGP, calls for MBS reforms to boost access to long-acting contraceptives

Health Industry Hub | October 4, 2024 |

Pharma News: Australian women are calling for more accurate information about their contraceptive options, with 70% feeling inadequately educated about […]

More


This content is copyright protected. Please subscribe to gain access.